View More View Less
  • 1 Debreceni Egyetem, Debrecen, Móricz Zs. krt. 22., 4032
Open access

Absztrakt:

A vérkészítményekhez való hozzáférés világszerte egyre korlátozottabbá válik. A rendelkezésre álló források észszerű felhasználása emiatt is kiemelt jelentőségű napjaink perioperatív betegellátásában. Az összes vérkészítmény-felhasználás közel fele a cardiovascularis sebészetben történik. A jelen közleményben összefoglaltuk a vérkészítmény-megtakarítás lehetséges módszereit a szívsebészeti betegellátás kapcsán, kiemelve a súlyos perioperatív vérzés kezelésével és megelőzésével kapcsolatos szempontokat. Orv Hetil. 2020; 161(37): 1579–1587.

If the inline PDF is not rendering correctly, you can download the PDF file here.

  • 1

    The Task Force on Patient Blood Management for Adult Cardiac Surgery of the European Association for Cardio-Thoracic Surgery (EACTS) and the European Association of Cardiothoracic Anaesthesiology (EACTA), Boer C, Meesters MI, Milojevic M, et al. 2017 EACTS/EACTA Guidelines on patient blood management for adult cardiac surgery. J Cardiothorac Vasc Anesth. 2018; 32: 88–120.

  • 2

    Kozek-Langenecker SA, Ahmed AB, Afshari A, et al. Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology: first update 2016. Eur J Anaesthesiol. 2017; 34: 332–395.

  • 3

    Vuylsteke A, Pagel C, Gerrard C, et al. The Papworth Bleeding Risk Score: a stratification scheme for identifying cardiac surgery patients at risk of excessive early postoperative bleeding. Eur J Cardiothorac Surg. 2011; 39: 924–930.

  • 4

    Gielen C, Dekkers O, Stijnen T, et al. The effects of pre- and postoperative fibrinogen levels on blood loss after cardiac surgery: a systematic review and meta-analysis. Interact Cardiovasc Thorac Surg. 2014; 18: 292–298.

  • 5

    Shariff N, Aleem A, Singh M, et al. AF and venous thromboembolism – pathophysiology, risk assessment and CHADS-VASc score. J Atr Fibrillation 2012; 5: 649.

  • 6

    Ghadimi K, Levy JH, Welsby IJ. Perioperative management of the bleeding patient. Br J Anaest. 2016; 117(Suppl 3): iii18–iii30.

  • 7

    Hassan K, Bayer N, Schlingloff F, et al. Bleeding complications after use of novel oral anticoagulants in patients undergoing cardiac surgery. Ann Thorac Surg. 2018; 105: 702–708.

  • 8

    Sousa-Uva M, Head SJ, Milojevic M, et al. 2017 EACTS Guidelines on perioperative medication in adult cardiac surgery. Eur J Cardiothorac Surg. 2018; 53: 5–33.

  • 9

    Mahdy AM, Webster NR. Perioperative systemic haemostatic agents. Br J Anaesth. 2004; 93: 842–858.

  • 10

    Crescenzi G, Landoni G, Biondi-Zoccai G, et al. Desmopressin reduces transfusion needs after surgery: a meta-analysis of randomized clinical trials. Anesthesiology 2008; 109: 1063–1076.

  • 11

    Desborough MJ, Oakland KA, Landoni G, et al. Desmopressin for treatment of platelet dysfunction and reversal of antiplatelet agents: a systematic review and meta-analysis of randomised controlled trials. J Thromb Haemost. 2017; 15: 263–272.

  • 12

    Myles PS, Smith JA, Forbes A, et al. Tranexamic acid in patients undergoing coronary-artery surgery. N Engl J Med. 2017; 376: 136–148. [Correction: N Engl J Med. 2018; 378: 782.]

  • 13

    Skhirtladze K, Base EM, Lassnigg A, et al. Comparison of the effects of albumin 5%, hydroxyethyl starch 130/0.4 6%, and Ringer’s lactate on blood loss and coagulation after cardiac surgery. Br J Anaesth. 2014; 112: 255–264.

  • 14

    Schramko A, Suojaranta-Ylinen R, Kuitunen A, et al. Hydroxyethylstarch and gelatin solutions impair blood coagulation after cardiac surgery: a prospective randomized trial. Br J Anaesth. 2010; 104: 691–697.

  • 15

    Rasmussen KC, Secher NH, Pedersen T. Effect of perioperative crystalloid or colloid fluid therapy on hemorrhage, coagulation competence, and outcome: A systematic review and stratified meta-analysis. Medicine (Baltimore) 2016; 95: e4498.

  • 16

    Weber CF, Görlinger K, Meininger D, et al. Point-of-care testing: a prospective, randomized clinical trial of efficacy in coagulopathic cardiac surgery patients. Anesthesiology 2012; 117: 531–547.

  • 17

    Lier H, Vorweg M, Hanke A, et al. Thromboelastometry guided therapy of severe bleeding. Essener Runde algorithm. Hamostaseologie 2013; 33: 51–61.

  • 18

    Fominskiy E, Nepomniashchikh VA, Lomivorotov VV, et al. Efficacy and safety of fibrinogen concentrate in surgical patients: a meta-analysis of randomized controlled trials. J Cardiothorac Vasc Anesth. 2016; 30: 1196–1204.

  • 19

    Ranucci M, Jeppsson A, Baryshnikova E. Pre-operative fibrinogen supplementation in cardiac surgery patients: an evaluation of different trigger values. Acta Anaesthesiol Scand. 2015; 59: 427–433.

  • 20

    Li JY, Gong J, Zhu F, et al. Fibrinogen concentrate in cardiovascular surgery: a meta-analysis of randomized controlled trials. Anesth Analg. 2018; 127: 612–621.

  • 21

    Wikkelsø A, Lunde J, Johansen M, et al. Fibrinogen concentrate in bleeding patients. Cochrane Database Syst Rev. 2013; 2013: CD008864.

  • 22

    Hajjar LA, Vincent JL, Galas FR, et al. Transfusion requirements after cardiac surgery: the TRACS randomized controlled trial. JAMA 2010; 304: 1559–1567.

  • 23

    Murphy GJ, Pike K, Rogers CA, et al. Liberal or restrictive transfusion after cardiac surgery. N Engl J Med. 2015; 372: 997–1008. [Correction: N Engl J Med. 2015; 372: 2274.]

  • 24

    Reeves BC, Pike K, Rogers CA, et al. A multicentre randomised controlled trial of transfusion indication threshold reduction on transfusion rates, morbidity and health-care resource use following cardiac surgery (TITRe2). Health Technol Assess. 2016; 20: 1–260.

  • 25

    Mazer CD, Whitlock RP, Fergusson DA, et al. Restrictive or liberal red-cell transfusion for cardiac surgery. N Engl J Med. 2017; 377: 2133–2144.